Michaela Levin
Förmögenhet: 61 500 $ per 2026-09-30
Förmögenhet: 61 500 $ per 2026-09-30
Michaela Levin is currently Chief Business Officer at Acrivon Therapeutics, Inc. Formerly, Dr. Levin was Vice President-Business Development at Recursion Pharmaceuticals, Inc. Dr. Levin earned a doctorate from the University of Virginia.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-08-31 | 30 000 ( 0,07 % ) | 61 500 $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| ACRIVON THERAPEUTICS, INC. | Företagsledare/Principal | 2026-08-31 |
| Företag | Position | Slut |
|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 3 |
|---|---|
Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that combines biology, chemistry, automation, data science and engineering to industrialize drug discovery | Health Technology |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acrivon Therapeutics, Inc.
Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån